# Consort Medical

> Consort Medical is a VC fund in Hemel Hempstead backing Health Care and Mobile. See 3 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: Hemel Hempstead, United Kingdom
- Total investments: 3
- Last investment: Jan 2017
- Lead investor: 0%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/consort-medical-plc
- X (Twitter): http://twitter.com/consortmedical
- Website: http://www.consortmedical.com

Consort Medical is a leading global contract development and manufacturing organisation (CDMO), providing advanced delivery technologies, formulation and manufacturing solutions for drugs.Their customers include some of the world’s largest pharmaceutical companies. Optimising world-class drug delivery device development and manufacture, togetherwith drug Active Pharmaceutical Ingredient (API) and finished dose formulation and manufacture, within the same Group streamlines and accelerates their pharmaceutical customers’ drug route to market.The Group is at the leading edge of innovation and is committed to investing in patient and customer driven innovation, with the potential to create new treatments, new markets and new opportunities.They also continue to diversify into adjacent complementary markets and technologies which leverage their core competencies in drug formulation, manufacturing and delivery.

## Contacts

5 contacts available for Consort Medical. Shizune tracks 2 team members at Consort Medical. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/consort-medical?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Mobile | 1 | 33% |
| Medical | 1 | 33% |
| Therapeutics | 1 | 33% |
| Biotechnology | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series C | 1 | 33% |
| Series D | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 33% |
| United Kingdom | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Paul Hayes | Chief Financial Officer | 0 | — |
| Peter Fellner | Chairman | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Binx Health | Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer | $35M | Series D | Jan 23, 2017 | https://mybinxhealth.com/ |
| Oxular | Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs. | $20.6M | Series A | Jul 19, 2016 | https://oxular.com/ |
| Binx Health | Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer | $20M | Series C | Jan 29, 2015 | https://mybinxhealth.com/ |

3 of 3 investments shown.

## Co-investors
- [BB Biotech Ventures](https://shizune.co/investors/profile/bb-biotech-ventures) — VC Fund, 2 deals together
- [Global Life Science Ventures](https://shizune.co/investors/profile/global-life-science-ventures) — VC Fund, 2 deals together
- [Johnson & Johnson Robotics and Digital Solutions](https://shizune.co/investors/profile/johnson-johnson-innovation) — VC Fund, 2 deals together
- [Novartis Venture Fund](https://shizune.co/investors/profile/novartis-venture-fund) — VC Fund, 2 deals together
- RMI Partners — VC Fund, 2 deals together
- Technology Venture Partners — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Consort Medical invest in?

Consort Medical invests primarily in Health Care, Mobile and Medical startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Consort Medical?

Public channels for Consort Medical include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Consort Medical?

The team at Consort Medical includes Paul Hayes (Chief Financial Officer) and Peter Fellner (Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co